Yong-Wha Moon

Yong-Wha Moon

UNVERIFIED PROFILE

Are you Yong-Wha Moon?   Register this Author

Register author
Yong-Wha Moon

Yong-Wha Moon

Publications by authors named "Yong-Wha Moon"

Are you Yong-Wha Moon?   Register this Author

36Publications

1060Reads

9Profile Views

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review.

Int J Cancer 2019 09 7;145(5):1179-1188. Epub 2019 Jan 7.

Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.32020
Publisher Site
http://dx.doi.org/10.1002/ijc.32020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767051PMC
September 2019

Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells.

J Immunother Cancer 2019 Aug 8;7(1):211. Epub 2019 Aug 8.

Institute for Clinical Research, CHA Bundang Medical Center, CHA University, Sungnam, Gyeonggi-do, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0688-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686217PMC
August 2019

IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells.

J Immunother Cancer 2019 Jul 5;7(1):168. Epub 2019 Jul 5.

Institute for Clinical Research, CHA Bundang Medical Center, CHA University, Sungnam, Gyeonggi-do, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0652-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612093PMC
July 2019

A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer.

Gynecol Oncol 2019 04 25;153(1):135-148. Epub 2019 Jan 25.

Department of Pathology, CHA Bundang Medical Center, CHA University, Republic of Korea; Institute for Clinical Research, CHA Bundang Medical Center, CHA University, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258193004
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2019.01.012DOI Listing
April 2019

Predictive factors for treatment response using dual-energy computed tomography in patients with advanced lung adenocarcinoma.

Eur J Radiol 2018 Apr 17;101:118-123. Epub 2018 Feb 17.

Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, 120-752, Seoul, Korea, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2018.02.019DOI Listing
April 2018

High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.

Lung Cancer 2018 02 15;116:38-45. Epub 2017 Dec 15.

Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC 20057, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.12.010DOI Listing
February 2018

EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.

Mol Cancer Ther 2016 07 11;15(7):1627-36. Epub 2016 May 11.

Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0375DOI Listing
July 2016

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.

Cancer Chemother Pharmacol 2016 Mar 25;77(3):539-48. Epub 2016 Jan 25.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-Gu, Seoul, 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-2968-zDOI Listing
March 2016

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.

BMC Cancer 2016 Mar 16;16:224. Epub 2016 Mar 16.

Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2251-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793740PMC
March 2016

Targeting the indoleamine 2,3-dioxygenase pathway in cancer.

J Immunother Cancer 2015 15;3:51. Epub 2015 Dec 15.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 455, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0094-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678703PMC
December 2015

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma.

Mol Cancer Ther 2015 Oct 24;14(10):2238-48. Epub 2015 Jul 24.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. Institute for Cancer Research, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0350DOI Listing
October 2015

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.

BMC Cancer 2013 Dec 6;13:583. Epub 2013 Dec 6.

Yonsei Cancer Center, Divison of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029391PMC
December 2013

Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen.

J Cancer Res Clin Oncol 2011 Jul 16;137(7):1123-30. Epub 2011 Feb 16.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-011-0976-2DOI Listing
July 2011

The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.

Ann Surg Oncol 2010 Dec 19;17(12):3259-68. Epub 2010 Jun 19.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-1172-3DOI Listing
December 2010

Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design.

Cancer Chemother Pharmacol 2010 Sep 11;66(4):797-805. Epub 2010 Mar 11.

Cancer Metastasis Research Center, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1295-zDOI Listing
September 2010

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance.

Cancer Chemother Pharmacol 2010 Aug 15;66(3):425-31. Epub 2009 Dec 15.

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1176-5DOI Listing
August 2010

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.

J Cancer Res Clin Oncol 2010 Mar 16;136(3):387-94. Epub 2009 Sep 16.

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0668-3DOI Listing
March 2010

Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer.

J Surg Oncol 2009 Nov;100(6):459-65

Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21347DOI Listing
November 2009

Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer.

Anticancer Res 2009 Oct;29(10):4243-9

Yonsei Cancer Center, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-gu, CPO Box 8044, Seoul 120-752, Korea.

View Article

Download full-text PDF

Source
October 2009

Prediction of high-risk patients by genome-wide copy number alterations from remaining cancer after neoadjuvant chemotherapy and surgery.

Int J Oncol 2009 Mar;34(3):837-46

Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000210DOI Listing
March 2009

A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusion.

Yonsei Med J 2007 Dec;48(6):1035-8

Yonsei Cancer Center, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3349/ymj.2007.48.6.1035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628172PMC
December 2007

Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer.

Breast Cancer Res Treat 2007 Jul 15;104(1):31-7. Epub 2007 Feb 15.

Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9398-2DOI Listing
July 2007

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer.

Cancer 2007 May;109(9):1845-950

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22621DOI Listing
May 2007

Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.

Cancer 2007 May;109(9):1829-35

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, and Department of Division of Hemato-Oncology, National Health Insurance Corp., Ilsan Hospital, Kyonggi-do, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22601DOI Listing
May 2007

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer.

Lung Cancer 2006 Dec 29;54(3):365-70. Epub 2006 Sep 29.

Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.08.014DOI Listing
December 2006

Congestive heart failure and a swollen breast.

Lancet 2004 Jan;363(9404):210

Cardiovascular Division of Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, 120-752, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(03)15327-5DOI Listing
January 2004